
Journal of Medicinal Chemistry p. 3757 - 3764 (2007)
Update date:2022-07-30
Topics:
Palmer, Brian D.
Henare, Kimiora
Woon, See-Tarn
Sutherland, Rachel
Reddy, Charu
Wang, Liang-Chuan S.
Kieda, Claudine
Ching, Lai-Ming
5,6-Dimethylxanthenone-4-acetic acid (1) is scheduled for phase III clinical trials as a vascular disrupting agent. However, its biochemical receptor(s) have yet to be identified. In this report, the synthesis of azido analogues of 1 that could be used fo
View MoreSICHUAN ZHONGBANG NEW MATERIAL CO., LTD
website:http://www.zhongbangst.com
Contact:86-830-2585019
Address:sichuan,china
Contact:13813902930 025-52714267
Address:20 Fengji Road, Yuhua Economic Development Zone, Nanjing, Jiangsu, P. R. China
website:http://www.aecochemical.com
Contact:+86-592 599 8717
Address:No 611 Sishui Road,Huli
Zibo Xiaoguang Chemical Material Co., Ltd
Contact:15954099116
Address:Boshan Development Zone
Tianjin Chemsyntech Chemical Co., Ltd
Contact:+86-22-60872258
Address:Haitai green industry base in Tianjin, K1,5-601
Doi:10.1070/MC2004v014n01ABEH001860
(2004)Doi:10.1021/jo01376a001
(1954)Doi:10.1021/jo00836a085
(1970)Doi:10.1016/S0277-5387(97)00109-5
(1997)Doi:10.1021/np020392i
(2003)Doi:10.1021/jacs.5b03619
(2015)